Effects of a Zumba Dance Program for Postmenopausal Women With Metabolic Syndrome

A study testing Zumba dance in people with Metabolic Syndrome, run by University of Basel at 1 site in Switzerland.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Trial summary

The aim of this study is to examine the effects of a 12-week Zumba dance intervention on fitness, anthropometric and psychometric parameters and eating behavior. Read more about this study

Who is it for?: Ages 45 to 65 years, women only
Conditions the study is for: Metabolic Syndrome
What is being tested?: Zumba dance
Could I receive a placebo?: No, everyone receives an active treatment
How many people: 17 participants
Where: 1 siteSwitzerland
Study dates: May 2014to Oct 2014
Phase: Interventional
Are there results?: None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

Ages 45 to 65 years
Women only
No healthy volunteers
Adult, Older adult

Who may be able to join

postmenopausal women (Age 45-65)
waist of >94 cm or BMI > 30kg/m2
not physically active >1x/week for 20 minutes
written consent before the start of the study

Who cannot join

involvement in other clinical studies
unable to participate at the dance lessons
medical contraindications for the intervention or increased risk for exercise participation

Trial locations and contacts

1 site in 1 country.

Switzerland1 site

Department for Sports, Exercise and Health, Sports and Exercise Medicine, University of Basel
Basel, 4052

Other trials in Switzerland

About this study

Official title: ZumBeat: Effekte Eines Rhythmusorientierten Aeroben Tanz-Bewegungsprogrammes für Postmenopausale Frauen Mit Metabolischem Syndrom

The aim of this study is to examine the effects of a 12-week Zumba dance intervention on fitness, anthropometric and psychometric parameters and eating behavior.

Conditions: Metabolic Syndrome
Being tested: Zumba dance
Keywords: cardiorespiratory fitness, weight, quality of life, depression, menopausal symptoms, exercise barriers, executive functions
Medical subject headings: Metabolic Syndrome, Body Weight, Depression

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

Zumba danceOther
Twelve weeks, 3 times weekly 1 hour training

Study groups in NCT02384694
Study group	Role	What they receive
Intervention	Experimental	Zumba dance intervention Receives: Other: Zumba dance

What is being measured

The primary outcome is the main question the study is designed to answer.

VO2peak (=peak oxygen consumption)
The VO2peak will be assessed for every participant during a treadmill spirometry at baseline and follow-up using a mask and calibrated gas measuring devices applying a standardized protocol.
Measured: VO2peak will be assessed at T1 and T12 (baseline and after 12 weeks of intervention)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

May 2014Oct 2014

First posted10 Mar 2015 (estimated)
Study startMay 2014
Primary completionOct 2014
Study completionOct 2014

Resources

Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
Other trials for Metabolic SyndromeStudies of the same condition, open and under way.
What the trial phases meanHow a treatment moves from first tests in people to approval.

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design

Study type: Interventional
Phase: Phase N/A
Primary purpose: Treatment
Allocation: Not applicable
Intervention model: Single group
Masking: None (open label)
Enrolment: 17 participants (actual)

IDs, dates and publications

ClinicalTrials.gov ID: NCT02384694
Sponsor's protocol ID: EKNZ 2014-033
Acronym: ZumBeat
Status last verified: Mar 2015
First submitted: 27 Feb 2015
Last updated: 10 Mar 2015
Results posted: No
Data monitoring committee: Yes

Want to know more?

The sponsor has not listed a contact. The official record may have more details.

Talk to your doctor first and take this page with you. Only the study team can confirm whether you can join.

Questions to ask the study team

What is the study trying to find out?
What would I need to do, and how often would I visit?
Could I receive a placebo instead of the treatment?
What are the possible risks and benefits for me?
Will it cost me anything? Are travel or time paid for?
Can I keep seeing my own doctor during the study?
What happens when the study ends?

See locations

RecruitingObservational study
Defining the Natural History of Squamous Cell Carcinoma in Fanconi Anemia
Fanconi Anemia, Inherited Bone Marrow Failure Syndrome
Not yet recruitingPhase 2
Osilodrostat for Glycemic Control in Mild Autonomous Cortisol Secretion (MACS) With Difficult-To-Control Type 2 Diabetes - A Randomized, Double-Blind, Placebo-Controlled Phase 2 Study
Mild Autonomous Cortisol Secretion (MACS), Diabetes Mellitus (Type 2)
Active, not recruiting
Effects of Whole-body Electrical Muscle Stimulation Exercise on Adults With Neuromuscular Disease
Neuromuscular Diseases (NMD), Amyotrophic Lateral Sclerosis
Not yet recruitingObservational study
Clinical Genetics Branch Eligibility Screening Survey
Melanoma, Li-Fraumeni Syndrome
Not yet recruitingPhase 2
Effects of Meal Macronutrients on Postprandial Lipids
Nephrotic Syndrome, Lipodystrophy

All Metabolic Syndrome trials

Study at a glance

From the registry record, last updated by the sponsor on 10 Mar 2015. Recruitment status is as the sponsor reported it: confirm with the study team.

Official title: ZumBeat: Effekte Eines Rhythmusorientierten Aeroben Tanz-Bewegungsprogrammes für Postmenopausale Frauen Mit Metabolischem Syndrom
ClinicalTrials.gov ID: NCT02384694
Acronym / sponsor ID: ZumBeat / EKNZ 2014-033
Conditions: Metabolic Syndrome
Keywords: cardiorespiratory fitness, weight, quality of life, depression, menopausal symptoms, exercise barriers, executive functions
Study type: Interventional
Recruitment status: Completed
Enrolment: 17 participants (actual)
Lead sponsor: University of BaselUniversity, hospital or other
Study start: May 2014
Primary completion: Oct 2014 (actual)
Study completion: Oct 2014 (actual)
First posted: 10 Mar 2015 (estimated)
Results: Not posted in the source record

Clinical summary

The research question as the sponsor registered it. This describes what the study plans to test, not what it found.

The aim of this study is to examine the effects of a 12-week Zumba dance intervention on fitness, anthropometric and psychometric parameters and eating behavior.

Study design

Primary purpose: Treatment
Allocation: Not applicable
Intervention model: Single group
Masking: None (open label)
Number of arms: 1

Arm	Type	Receives
Intervention	Experimental	Other: Zumba danceZumba dance intervention

Who may qualify

Ages: 45 to 65 years
Sex: Female only
Healthy volunteers: Not accepted
Age groups: Adult, Older adult

Key inclusion criteria (4 listed)

postmenopausal women (Age 45-65)
waist of >94 cm or BMI > 30kg/m2
not physically active >1x/week for 20 minutes
written consent before the start of the study

Key exclusion criteria (3 listed)

involvement in other clinical studies
unable to participate at the dance lessons
medical contraindications for the intervention or increased risk for exercise participation

Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.

Interventions

Intervention	Type	Arms
Zumba danceTwelve weeks, 3 times weekly 1 hour training	Other	Intervention

Primary outcome

VO2peak (=peak oxygen consumption)
Time frame: VO2peak will be assessed at T1 and T12 (baseline and after 12 weeks of intervention)
The VO2peak will be assessed for every participant during a treadmill spirometry at baseline and follow-up using a mask and calibrated gas measuring devices applying a standardized protocol.

Results and safety

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

Research links

Official record on ClinicalTrials.govLast updated by the sponsor 10 Mar 2015.

Related trials for Metabolic Syndrome

RecruitingObservational study
Defining the Natural History of Squamous Cell Carcinoma in Fanconi Anemia
Fanconi Anemia, Inherited Bone Marrow Failure Syndrome
Not yet recruitingPhase 2
Osilodrostat for Glycemic Control in Mild Autonomous Cortisol Secretion (MACS) With Difficult-To-Control Type 2 Diabetes - A Randomized, Double-Blind, Placebo-Controlled Phase 2 Study
Mild Autonomous Cortisol Secretion (MACS), Diabetes Mellitus (Type 2)
Active, not recruiting
Effects of Whole-body Electrical Muscle Stimulation Exercise on Adults With Neuromuscular Disease
Neuromuscular Diseases (NMD), Amyotrophic Lateral Sclerosis
Not yet recruitingObservational study
Clinical Genetics Branch Eligibility Screening Survey
Melanoma, Li-Fraumeni Syndrome
Not yet recruitingPhase 2
Effects of Meal Macronutrients on Postprandial Lipids
Nephrotic Syndrome, Lipodystrophy

Referral and contact

AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.

Arno Schmidt-Trucksäss, Prof. Dr. principal investigator

Sports and Exercise Medicine, Department of Sports, Exercise and Health, University of Basel

1 site in 1 country: see every site and its status.

Questions about this trial

What is this clinical trial studying?

A study testing Zumba dance in people with Metabolic Syndrome, run by University of Basel at 1 site in Switzerland.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 10 Mar 2015. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Switzerland. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

VO2peak (=peak oxygen consumption) (time frame: VO2peak will be assessed at T1 and T12 (baseline and after 12 weeks of intervention)). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT02384694.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 10 Mar 2015.